Your browser doesn't support javascript.
loading
Altered binding avidities and improved growth inhibitory effects of novel anti-HER3 mAb against human cancers in the presence of HER1-or HER2-targeted drugs.
Okita, Kouki; Imai, Kazuki; Kato, Kazunori; Sugiura, Reiko; Endo, Yuichi; Masuko, Kazue; Tomioka, Yoshihisa; Masuko, Takashi.
Afiliação
  • Okita K; Cell Biology Laboratory, School of Pharmacy, Kindai University, Higashiosaka-shi, Osaka, Japan; Laboratory of Molecular Pharmacogenomics, Faculty of Pharmacy, Kindai University, Japan; Production and Manufacturing, Carna Biosciences, Inc., Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
  • Imai K; Cell Biology Laboratory, School of Pharmacy, Kindai University, Higashiosaka-shi, Osaka, Japan.
  • Kato K; Department of Biomedical Engineering, Toyo University, Kawagoe-shi, Saitama, Japan.
  • Sugiura R; Laboratory of Molecular Pharmacogenomics, Faculty of Pharmacy, Kindai University, Japan.
  • Endo Y; Laboratory of Natural Drug Resources, Faculty of Pharmacy, Kindai University, Japan.
  • Masuko K; Cell Biology Laboratory, School of Pharmacy, Kindai University, Higashiosaka-shi, Osaka, Japan.
  • Tomioka Y; Laboratory of Oncology Pharmacy Practice and Science, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai-shi, Miyagi, Japan.
  • Masuko T; Cell Biology Laboratory, School of Pharmacy, Kindai University, Higashiosaka-shi, Osaka, Japan; Laboratory of Natural Drug Resources, Faculty of Pharmacy, Kindai University, Japan. Electronic address: masuko@phar.kindai.ac.jp.
Biochem Biophys Res Commun ; 576: 59-65, 2021 10 22.
Article em En | MEDLINE | ID: mdl-34482024

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor ErbB-2 / Receptor ErbB-3 / Anticorpos Monoclonais / Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor ErbB-2 / Receptor ErbB-3 / Anticorpos Monoclonais / Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão